|Videos|March 31, 2020
Ep. 6: Identifying Nonmetastatic CRPC
Advertisement
Episodes in this series
Transcript:
Advertisement
Related to this article
Faculty convened at an OncLive Scientific Interchange and Workshop to weigh how new regimens should reshape sequencing in prostate cancer.
Focal therapy for prostate cancer has evolved over 2 decades, with advances in imaging, patient selection, treatment modalities, and clinical trials.
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
2
B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer
3
The OncFive: Top Oncology Articles for the Week of 8/30
4
Novel Analysis Reveals Millions of Life-Years Saved by Blood Cancer Treatments
5